Heron Therapeutics is a California-based biotechnology company that develops and commercializes novel medicines for the treatment of cancer.Read more
Heron's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 8.8B. Over the last four quarters, Heron's revenue has grown by 12.4%. Specifically, in Q2 2021's revenue was $22.4M; in Q1 2021, it was $20M; in Q4 2020, it was $20.6M; in Q3 2020, Heron's revenue was $20M.